search
Back to results

Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia (Mini-VINO)

Primary Purpose

Cardiovascular Abnormalities

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
B12-Folic Acid, nitrous oxide
Nitrous oxide (NO) and placebo
Placebo
oxygen nitrogen
Sponsored by
Washington University School of Medicine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Cardiovascular Abnormalities focused on measuring Nitrous oxide, cobalamin, homocysteine, vitamin B12, folate, No specific diseases targeted

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patients scheduled for elective surgery with expected duration > 2 hours
  • Healthy patients undergoing moderate surgery where the use of N2O is unproblematic

Exclusion Criteria:

  • Contraindication against N2O (pneumothorax, mechanical bowel obstruction, middle ear occlusion, laparoscopic surgery, raised intracranial pressure)
  • Patients requiring supplemental oxygen
  • Urgent or emergent surgery
  • Patients with vitamin B12 or folate deficiency or megaloblastic anemia
  • Patients with seizure disorder (epilepsy)
  • Allergy or hypersensitivity against IV cobalamin or folate
  • Patients with Leber's disease (hereditary optic nerve atrophy)
  • Patients taking supplemental vitamin B12 or folate

Sites / Locations

  • Barnes Jewish Hospital

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

Placebo Comparator

Arm Label

Treatment 1

Treatment 2

Control group

Arm Description

B12-Folic acid, nitrous oxide

Nitrous oxide (NO) and placebo

oxygen nitrogen

Outcomes

Primary Outcome Measures

Change in Plasma Total Homocysteine Concentration (tHcy)
Difference between baseline (pre-operative) and peak postoperative (i.e., maximum of postoperative value obtained within 30 minutes after anesthesia end time and morning of post-operative day 1) tHcy concentration . Of note: there were no secondary outcomes.

Secondary Outcome Measures

Full Information

First Posted
May 8, 2009
Last Updated
August 31, 2020
Sponsor
Washington University School of Medicine
Collaborators
Foundation for Anesthesia Education and Research
search

1. Study Identification

Unique Protocol Identification Number
NCT00901394
Brief Title
Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia
Acronym
Mini-VINO
Official Title
Influence of Preoperative Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia
Study Type
Interventional

2. Study Status

Record Verification Date
August 2020
Overall Recruitment Status
Completed
Study Start Date
March 2009 (undefined)
Primary Completion Date
January 2010 (Actual)
Study Completion Date
January 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Washington University School of Medicine
Collaborators
Foundation for Anesthesia Education and Research

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this study is to find out if giving intravenous B-vitamins before general anesthesia with nitrous oxide prevents the increase in homocysteine, a metabolite that has been linked to cardiovascular complications.
Detailed Description
Patients will be randomized into the following arms: Arm A: patients will receive N2O (60% N2O/40% O2) in an open-label fashion during surgery and vitamin supplementation (vitamin B12, 1 mg, and folate, 5 mg) before surgery. Arm B: patients will receive N2O 60% N2O/40% O2) in an open-label fashion during surgery and placebo before and after surgery. Arm C: patients will not receive N2O, vitamin supplementation, or placebo during/before surgery. Patients in this arm will not be randomized. Patients will have blood drawn (total of 1-2 teaspoons over 3 days). We will take these samples before their surgery, when their surgery is completed, and in the morning of post-operative day 1. We will be checking their troponin I and troponin T, homocysteine, Vitamin B12, and folate levels. We will also perform a 12-lead EKG. Before and after surgery for patients in Arm A or B, will receive either vitamin B12 (1 mg) and folic acid (5 mg) (or placebo) added to their IV infusion. We also plan to use a non-invasive test known as a nerve conduction study to measure the function of their nerve system. Briefly, 2 small electrodes are attached to their skin over a nerve and, like an EKG, faint electrical pulses are generated and recorded. A typical nerve conduction measurement lasts about 10 minutes. After the patients surgery we will do genetic testing of MTHFR genotype. All study samples have been collected. Of note: there were no secondary outcomes.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiovascular Abnormalities
Keywords
Nitrous oxide, cobalamin, homocysteine, vitamin B12, folate, No specific diseases targeted

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
63 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Treatment 1
Arm Type
Experimental
Arm Description
B12-Folic acid, nitrous oxide
Arm Title
Treatment 2
Arm Type
Active Comparator
Arm Description
Nitrous oxide (NO) and placebo
Arm Title
Control group
Arm Type
Placebo Comparator
Arm Description
oxygen nitrogen
Intervention Type
Drug
Intervention Name(s)
B12-Folic Acid, nitrous oxide
Other Intervention Name(s)
b supplements
Intervention Description
IV vitamin B12 (cyanocobalamin) 1 mg, single administration over 30 min. IV folic acid, 5 mg, single administration over 30 min. Both diluted in 250 ml normal saline.
Intervention Type
Drug
Intervention Name(s)
Nitrous oxide (NO) and placebo
Other Intervention Name(s)
nitrous oxide
Intervention Description
60% nitrous oxide anesthesia plus saline
Intervention Type
Other
Intervention Name(s)
Placebo
Other Intervention Name(s)
saline
Intervention Description
Saline
Intervention Type
Other
Intervention Name(s)
oxygen nitrogen
Other Intervention Name(s)
air
Intervention Description
60% air and oxygen mix.
Primary Outcome Measure Information:
Title
Change in Plasma Total Homocysteine Concentration (tHcy)
Description
Difference between baseline (pre-operative) and peak postoperative (i.e., maximum of postoperative value obtained within 30 minutes after anesthesia end time and morning of post-operative day 1) tHcy concentration . Of note: there were no secondary outcomes.
Time Frame
Immediately postoperatively and on postoperative day 1

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adult patients scheduled for elective surgery with expected duration > 2 hours Healthy patients undergoing moderate surgery where the use of N2O is unproblematic Exclusion Criteria: Contraindication against N2O (pneumothorax, mechanical bowel obstruction, middle ear occlusion, laparoscopic surgery, raised intracranial pressure) Patients requiring supplemental oxygen Urgent or emergent surgery Patients with vitamin B12 or folate deficiency or megaloblastic anemia Patients with seizure disorder (epilepsy) Allergy or hypersensitivity against IV cobalamin or folate Patients with Leber's disease (hereditary optic nerve atrophy) Patients taking supplemental vitamin B12 or folate
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Nagele, MD
Organizational Affiliation
Washington University School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Barnes Jewish Hospital
City
Saint Louis
State/Province
Missouri
ZIP/Postal Code
63110
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
18580170
Citation
Nagele P, Zeugswetter B, Wiener C, Burger H, Hupfl M, Mittlbock M, Fodinger M. Influence of methylenetetrahydrofolate reductase gene polymorphisms on homocysteine concentrations after nitrous oxide anesthesia. Anesthesiology. 2008 Jul;109(1):36-43. doi: 10.1097/ALN.0b013e318178820b.
Results Reference
background
PubMed Identifier
19339913
Citation
Nagele P, Zeugswetter B, Eberle C, Hupfl M, Mittlbock M, Fodinger M. A common gene variant in methionine synthase reductase is not associated with peak homocysteine concentrations after nitrous oxide anesthesia. Pharmacogenet Genomics. 2009 May;19(5):325-9. doi: 10.1097/FPC.0b013e328328d54c.
Results Reference
background
PubMed Identifier
18813045
Citation
Myles PS, Chan MT, Kaye DM, McIlroy DR, Lau CW, Symons JA, Chen S. Effect of nitrous oxide anesthesia on plasma homocysteine and endothelial function. Anesthesiology. 2008 Oct;109(4):657-63. doi: 10.1097/ALN.0b013e31818629db.
Results Reference
background

Learn more about this trial

Vitamin B12 and Folate Administration on Homocysteine Concentrations After Nitrous Oxide Anesthesia

We'll reach out to this number within 24 hrs